Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Relevance of the Major Pathologic Regression for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Multi-center Study

NCT06879197 is registered in ClinicalTrials.gov with Yanhong Deng as lead sponsor.

NCT NCT06879197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06879197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Relevance of the Major Pathologic Regression for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Multi-center Study
Lead sponsor
Yanhong Deng
Phase
Observational
Overall status
Completed
Start date
April 30, 2016
Completion date
March 30, 2023
Enrollment
1,187 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, rectal neoplasms